event-trade登录编辑
🇺🇸 SECElastic N.V.Doubao · 实盘不做把握 9/10不做原因:无增量信息
北京时间·🕒 发布 04:09:43·⟳ 抓取 04:10:14 +31s·⚡ 决策 10-16 04:10:59 +45s·12.0 天前

Elastic N.V. 8-K 仅披露年度股东大会十一项议案投票结果,全部通过,属例行治理备案

该 8-K 仅为 Item 5.07 股东大会投票结果的行政性法定备案,所有议案均按董事会推荐通过,未包含任何相对市场预期的新增基本面事实;股份发行/回购授权属于年会例行授权而非新增资本运作,Web、行情或供应链研究均不可能将其变为可交易催化。

📄 原文Elastic N.V.↗ 原文
----- estc-20261015.htm ----- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT…
不做 Elastic N.V.(ESTC.US)
8-K Item 5.07 年会投票结果为例行治理备案,全部议案照章通过,无业绩、指引、重大合同、并购或新增回购等增量事实,无交易 edge;个别董事/薪酬议案反对票偏高仅为长期治理噪音,不构成做空催化
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)

研究档案

结论摘要

Elastic 年会十一项议案全部照章通过,是典型的例行治理披露,无预期差、无新增经营或资本配置事实,不具交易 edge,回避。

🔎 新鲜度:最早出现 2026-10-15 · 扩散 low · price-in 风险 low ↗

主要风险

  • Gleeson 任命与 say-on-pay 出现较高反对票,或反映部分股东治理不满,但属长期治理议题,不改变短期交易判断

先例如何影响了这次决策

对本次决策的影响:确认无需为该备案设定任何交易或止盈止损

方向:年会投票结果(Item 5.07)属例行行政备案,历史上不构成方向性催化,故不检索/构建价格先例

涨幅量级:无对齐先例可用于定幅,因事件本身无交易价值

形态:不适用

原文全文

展开原文 · 9,022 字
----- estc-20261015.htm -----
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
October 15, 2026
Elastic N.V.
(Exact name of registrant as specified in its charter)
The
Netherlands
(State or other jurisdiction
of incorporation)
001-38675
(Commission File Number)
98-1756035
(I.R.S. Employer
Identification Number)
Not Applicable
1
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: Not Applicable
1
N/A
(Former name or former address if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange of which registered
Ordinary Shares, €0.01 Par Value
ESTC
The New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
1
We are a distributed company. Accordingly, we do not have a principal executive office. For purposes of compliance with applicable requirements of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, any shareholder communication required to be sent to our principal executive offices may be directed to the email address ir@elastic.co or to Elastic N.V., 33 New Montgomery St., 9th Floor, San Francisco, California 94105.
Item 5.07. Submission of Matters to a Vote of Security Holders.
(a) On October 15, 2026, Elastic N.V. (“Elastic” or the “Company”) held an annual general meeting of shareholders (the “Annual Meeting”) at the Company’s offices at Keizersgracht 281, 1016 ED Amsterdam, the Netherlands. At the Annual Meeting, the Company’s shareholders voted on eleven proposals.
The proposals are described in the Company’s definitive proxy statement on Schedule 14A for the Annual Meeting filed with the Securities and Exchange Commission on August 28, 2026 (the “2026 proxy statement”).
(b) As of the close of business on September 17, 2026, the record date for the Annual Meeting (the “Record Date”), there were 105,980,172 ordinary shares of Elastic issued and outstanding and entitled to vote at the Annual Meeting, which excludes 3,024,920 ordinary shares held in treasury and not entitled to vote. As of the Record Date, there were no preferred shares of Elastic issued and outstanding. At least one-third of the issued and outstanding Elastic shares were present or represented at the Annual Meeting with respect to the proposals below, constituting a quorum for purposes of each proposal.
The certified final voting results with respect to the proposals voted on at the Annual Meeting are set forth below. Each proposal was adopted by the shareholders.
Proposal No. 1 – Appointments of Paul Auvil, Alison Gleeson, and Julia Liuson as non-executive directors, each for a term of three years, ending at the close of the 2029 annual general meeting of shareholders:
Nominee
For
Against
Abstain
Broker Non-Votes
Paul Auvil
84,583,966
1,749,656
19,796
9,115,913
Alison Gleeson
55,084,238
31,250,435
18,745
9,115,913
Julia Liuson
85,597,409
735,964
20,045
9,115,913
Less than a two-thirds majority of the votes cast were cast against such nominee, and therefore Paul Auvil, Alison Gleeson and Julia Liuson were appointed in accordance with the Company's Articles of Association.
Proposal No. 2 – Adoption of the Company’s Dutch statutory annual accounts for the fiscal year ended April 30, 2026 (“Fiscal Year 2026”), which are prepared in accordance with International Financial Reporting Standards:
For
Against
Abstain
95,041,683
180,238
247,410
There were no broker non-votes with respect to this proposal.
The proposal received the affirmative vote of a majority of the votes cast and therefore passed.
Proposal No. 3 – Appointment of PricewaterhouseCoopers Accountants N.V. as the external auditor of the Company’s Dutch statutory annual accounts for the fiscal year ending April 30, 2027 (“Fiscal Year 2027”):
For
Against
Abstain
95,007,294
343,236
118,801
There were no broker non-votes with respect to this proposal.
The proposal received the affirmative vote of a majority of the votes cast and therefore passed.
Proposal No. 4 – Ratification of the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for Fiscal Year 2027:
For
Against
Abstain
95,013,023
343,842
112,466
There were no broker non-votes with respect to this proposal.
The proposal received the affirmative vote of a majority of the votes cast and therefore passed.
Proposal No. 5 – Grant of full discharge to the Company’s executive directors from their liability with respect to the performance of their duties as executive directors of the Company during Fiscal Year 2026:
For
Against
Abstain
Broker Non-Votes
86,071,463
97,323
184,632
9,115,913
The proposal received the affirmative vote of a majority of the votes cast and therefore passed.
Proposal No. 6 – Grant of full discharge to the Company’s non-executive directors from their liability with respect to the performance of their duties as non-executive directors of the Company during Fiscal Year 2026:
For
Against
Abstain
Broker Non-Votes
86,073,546
95,011
184,861
9,115,913
The proposal received the affirmative vote of a majority of the votes cast and therefore passed.
Proposal No. 7 – Authorization of the Company's board of directors (the “Board”) to issue ordinary shares and grant rights to acquire ordinary shares:
For
Against
Abstain
94,538,112
871,335
59,884
There were no broker non-votes with respect to this proposal.
The proposal received the affirmative vote of a majority of the votes cast and therefore passed.
Proposal No. 8 – Authorization of the Board to restrict or exclude pre-emptive rights for issuances of ordinary shares and grants of rights:
For
Against
Abstain
93,574,378
1,833,315
61,638
There were no broker non-votes with respect to this proposal. T
he proposal received the affirmative vote of a majority of the votes cast and, because more than half of the issued and outstanding ordinary shares of the Company were present or represented at the Annual Meeting, therefore passed.
Proposal No. 9 – Authorization of the Board to repurchase ordinary shares in the capital of the Company:
For
Against
Abstain
94,146,417
1,114,233
208,681
There were no broker non-votes with respect to this proposal.
The proposal received the affirmative vote of a majority of the votes cast and therefore passed.
Proposal No. 10 – Non-binding advisory vote on the compensation of the Company's named executive officers as described in the 2026 proxy statement:
For
Against
Abstain
Broker Non-Votes
72,833,321
13,381,500
138,597
9,115,913
The shareholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers by the affirmative vote of a majority of the votes cast.
Proposal No. 11 – Non-binding advisory vote on the frequency of future non-binding advisory votes to approve the compensation of the Company's named executive officers:
1 Year
2 Years
3 Years
Abstain
Broker Non-Votes
85,232,883
5,171
548,737
566,627
9,115,913
The shareholders indicated, on a non-binding advisory basis, their preference for one year as the frequency of holding future non-binding advisory votes on the compensation of the Company's named executed officers. Based on these results, and consistent with the Board’s recommendation to shareholders, the Company will include a non-binding advisory vote on the compensation of the Company’s named executive officers in the Company’s proxy statement every year until the next required vote on the frequency of such votes.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: October 15, 2026
ELASTIC N.V.
By:
/s/ Navam Welihinda
Name:
Navam Welihinda
Title:
Chief Financial Officer

决策记录链 · 只追加

每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。

  1. 6668b1e893 · 2026-10-16 04:10 · doubao / doubao-seed-evolving-latest-version · 策略包 2226518bfdee当前